Quantum Biopharma (QNTM) Inventory Average (2025 - 2026)
Quantum Biopharma's (QNTM) quarterly Inventory Average came in at $52240.0 in Q2 2026, down 38.8% year-over-year from $85362.5 in Q2 2025, and up 0.85% quarter-over-quarter from $51800.5 in Q1 2026.
Powered by 
Analysis
Quantum Biopharma (QNTM) Inventory Average (2025 - 2026) Analysis & Trends
Quantum Biopharma has disclosed Inventory Average across 2 years of filings, most recently posting $52240.0 for Q2 2026.
- In Q2 2026, Inventory Average fell 38.8% year-over-year to $52240.0; the TTM figure through Jun 2026 stood at $52240.0 (down 38.8% YoY), while the FY2025 annual figure was $84687.5, changed N/A from the prior year.
- Inventory Average came in at $52240.0 for Q2 2026 at Quantum Biopharma, up from $51800.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $105549.0 in Q1 2025 to a low of $51800.5 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.77 Bn | 195.78 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 131.81 Bn | 123.96 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.07 Bn | 74.07 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 61.31 Bn | 56.12 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.58 Bn | 48.44 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.65 Bn | 30.34 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.73 Bn | 30.44 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.65 Bn | 29.65 Bn | 1.16 Mn | - |
| 10 | Quantum Biopharma | 11.60 Mn | 7.95 Mn | - | 52,240.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52,240.00 |
| Mar 31, 2026 | 51,800.50 |
| Dec 31, 2025 | 64,877.50 |
| Sep 30, 2025 | 77,245.50 |
| Jun 30, 2025 | 85,362.50 |
| Mar 31, 2025 | 105,549.00 |